These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35006660)

  • 21. Anticoagulants or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter.
    Segal JB; McNamara RL; Miller MR; Powe NR; Goodman SN; Robinson KA; Bass EB
    Cochrane Database Syst Rev; 2001; (1):CD001938. PubMed ID: 11279741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonvitamin-K-antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and previous stroke or transient ischemic attack: An updated systematic review and meta-analysis of randomized controlled trials.
    Ntaios G; Papavasileiou V; Diener HC; Makaritsis K; Michel P
    Int J Stroke; 2017 Aug; 12(6):589-596. PubMed ID: 28730948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
    Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
    Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease.
    Kimachi M; Furukawa TA; Kimachi K; Goto Y; Fukuma S; Fukuhara S
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011373. PubMed ID: 29105079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors associated with non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II).
    Steinberg BA; Shrader P; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Hylek E; Kowey PR; Mahaffey KW; O'Brien EC; Singer DE; Peterson ED; Piccini JP;
    Am Heart J; 2017 Jul; 189():40-47. PubMed ID: 28625380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Warfarin versus aspirin: using CHADS2 to guide therapy for stroke prevention in nonvalvular atrial fibrillation.
    Hopps S; Marcy TR
    Consult Pharm; 2009 Nov; 24(11):841-4. PubMed ID: 20092222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atrial fibrillation and cardioembolic stroke.
    Ferro JM
    Minerva Cardioangiol; 2004 Apr; 52(2):111-24. PubMed ID: 15194993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Temporal Trends in the Use and Comparative Effectiveness of Direct Oral Anticoagulant Agents Versus Warfarin for Nonvalvular Atrial Fibrillation: A Canadian Population-Based Study.
    Yu AYX; Malo S; Svenson LW; Wilton SB; Hill MD
    J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29080863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation and management of atrial fibrillation.
    Ali S; Hong M; Antezano ES; Mangat I
    Cardiovasc Hematol Disord Drug Targets; 2006 Dec; 6(4):233-44. PubMed ID: 17378769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Critical appraisal of network meta-analyses evaluating the efficacy and safety of new oral anticoagulants in atrial fibrillation stroke prevention trials.
    Cope S; Clemens A; Hammès F; Noack H; Jansen JP
    Value Health; 2015 Mar; 18(2):234-49. PubMed ID: 25773559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.
    Arihiro S; Todo K; Koga M; Furui E; Kinoshita N; Kimura K; Yamagami H; Terasaki T; Yoshimura S; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Nagakane Y; Kameda T; Hasegawa Y; Shibuya S; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Matsuki T; Homma K; Takasugi J; Tokunaga K; Sato S; Kario K; Kitazono T; Toyoda K;
    Int J Stroke; 2016 Jul; 11(5):565-74. PubMed ID: 26927811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Barriers to warfarin use for stroke prevention in patients with atrial fibrillation in Hong Kong.
    Lee VW; Tam CS; Yan BP; Man Yu C; Yin Lam Y
    Clin Cardiol; 2013 Mar; 36(3):166-71. PubMed ID: 23151816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bleeding and stroke risk in a real-world prospective primary prevention cohort of patients with atrial fibrillation.
    Poli D; Testa S; Antonucci E; Grifoni E; Paoletti O; Lip GYH
    Chest; 2011 Oct; 140(4):918-924. PubMed ID: 21511826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of aspirin for stroke prevention in atrial fibrillation.
    Lip GY
    Nat Rev Cardiol; 2011 Jul; 8(10):602-6. PubMed ID: 21788962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline.
    Goldstein LB; Adams R; Alberts MJ; Appel LJ; Brass LM; Bushnell CD; Culebras A; Degraba TJ; Gorelick PB; Guyton JR; Hart RG; Howard G; Kelly-Hayes M; Nixon JV; Sacco RL; ; ; ; ; ; ;
    Stroke; 2006 Jun; 37(6):1583-633. PubMed ID: 16675728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Atrial fibrillation and apoplexy--risks and prevention].
    Koefoed BG; Gulløv AL; Petersen P
    Nord Med; 1996 Jun; 111(6):171-5. PubMed ID: 8700641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of novel oral anticoagulants for patients with atrial fibrillation: systematic review and clinical implications.
    Albert NM
    Heart Lung; 2014; 43(1):48-59. PubMed ID: 24373340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
    You JJ; Singer DE; Howard PA; Lane DA; Eckman MH; Fang MC; Hylek EM; Schulman S; Go AS; Hughes M; Spencer FA; Manning WJ; Halperin JL; Lip GYH
    Chest; 2012 Feb; 141(2 Suppl):e531S-e575S. PubMed ID: 22315271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monotherapy of acetylsalicylic acid or warfarin for prevention of ischemic stroke in low-risk atrial fibrillation: A Easter Asian population-based study.
    Liu CY; Chen HC
    Cardiol J; 2019; 26(6):704-710. PubMed ID: 29718533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Warfarin and Aspirin Use for Stroke Prevention Among Patients With Atrial Fibrillation: The US National Health and Wellness Survey.
    Goren A; Liu X; Gupta S; Simon TA; Phatak H
    Am J Ther; 2015; 22(4):248-56. PubMed ID: 24326696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.